Latest Regulatory Milestones News

Atomo Diagnostics has secured a US$410,000 order from Lumos Diagnostics for its Pascal test cassettes, following Lumos's exclusive six-year US distribution deal for the FebriDx test with PHASE Scientific.

Nanosonics has secured FDA clearance for its next-generation trophon3 device and trophon2 Plus software upgrade, setting the stage for significant growth in the US medical disinfection market.

Barton Gold Holdings has secured new exploration tenements for its Wudinna Gold Project, marking a pioneering M&A deal under South Australia’s updated mining regulations. This milestone strengthens Barton’s foothold in the region and sets a fresh precedent for future mining investments.

Horseshoe Metals advances its Horseshoe Lights copper-gold project with mining approval secured, site mobilization underway, and new drilling planned to expand resources.

EBR Systems has won final CMS approval for New Technology Add-On Payment reimbursement, paving the way for Medicare coverage of its innovative WiSE cardiac pacing system starting October 2025.

Lotus Resources has received the final environmental and social approval to restart its Kayelekera Uranium Mine in Malawi, marking a key milestone in its African uranium operations. This endorsement from Malawi’s Environment Protection Authority paves the way for the company’s planned production ramp-up.

Everest Metals Corporation has secured regulatory approval to begin mining at its Mt Dimer Taipan Gold & Silver Project, targeting production commencement in late 2025. The project’s inferred resource and ongoing contract negotiations position EMC for a promising small-scale operation.

Syntara Limited’s trading suspension has been lifted as the company lodged its quarterly activity and cash flow reports for June 2025, reopening its shares to market activity.

Strike Resources has made significant progress on its Apurimac Iron Ore Project in Peru, engaging with government agencies on critical railway infrastructure and initiating environmental studies, despite recent civil unrest impacting operations. Meanwhile, its stake in Lithium Energy Limited sees advancement in key lithium and gold-copper projects.

Recce Pharmaceuticals advances its clinical pipeline with expanded Phase 3 trials in Indonesia and Australia, backed by a $15.8 million capital raise and a $30 million debt facility.

TG Metals has completed the acquisition of an 80% stake in the Van Uden Gold Project, updated its mineral resource estimate to JORC 2012 standards, and begun drilling historical stockpiles with initial assay results received.

4DMedical has landed a $10 million strategic investment from Pro Medicus, aimed at accelerating its commercial growth and advancing its CT – VQ™ technology towards FDA clearance in the US.